Press Release
Sep 10, 2021
Chris Martin, IASLC Media Relations | cmartin@davidjamesgroup.com | 630.670.2745
September 10, 2021
What: The International Association for the Study of Lung Cancer (IASLC) 2021 World Conference on Lung Cancer Press Briefing featuring abstracts from the Presidential Symposium
When: Friday, September 10, 2021, 9 a.m.GMT/10 a.m. CDT/11 a.m. EDT
About: Each IASLC World Conference on Lung Cancer highlights the best in lung cancer research. Like the previous two meetings, this conference will be virtual. Each press briefing will be moderated by an IASLC member and include an IASLC Patient Research Advocate, to provide a unique perspective on how research may affect patients coping with lung cancer.
Zoom link: https://zoom.us/j/7540703378?pwd=SDFGUUQyZHgwMFJKRVB1MW5MSTk2UT09
Moderator: Heather Wakelee, MD, IASLC President-elect
Panelists:
Raymond Osarogiagbon, MD
OA06.04: Constructing a global molecular database for thoracic malignancies: the IASLC Molecular Subcommittee lung cancer dataset.
Ernest Nadal, MD
OA09.02: Atezo-brain: Single arm phase II study of atezolizumab plus chemotherapy in stage IV NSCLC with untreated brain metastases.
Jason Liu, MD
MA06.05: Patterns of Care in Maintenance Therapy in U.S. Patients Undergoing Definitive Chemoradiation for Stage 3 Non-Small Cell Lung Cancer (NCSLC).
Janelle Schrag, MPH
OA10.01: Perceptions of biomarker testing for underserved patients with lung cancer: a mixed-methods survey of US-based oncology clinicians.
Ericka Hlavacek
Patient Research Advocate
Andrew Ciupek, PhD
Patient Research Advocate
- Press briefings will be conducted via Zoom and recordings will be sent after the briefing concludes.
- Embargoes: abstracts that are part of the press program will be embargoed for beginning of each day’s press briefing. The IASLC reserves the right to change an embargo to account for a journal publication or other issues.
- Media Registration: If you have not registered to cover the meeting, visit https://wclc2021.iaslc.org/.